Clinical trial Recruiting at 1 site Interventional Ages 4 to 12

Oral Premedication Choices to Help Kids Tolerate Venipuncture in Day-Case Surgery

Official title: A Comparative Evaluation of Oral Premedication Regimens in Pediatric Patients Undergoing Ambulatory Surgery

Run by Diskapi Yildirim Beyazit Education and Research Hospital · NCT07410078 · Data updated 2026-11-12

This study tests whether giving oral midazolam alone or with ibuprofen or ketamine helps children ages 4–12 tolerate vein access better during ambulatory procedures.

More Pediatric Anesthesia trials

Quick facts

Study typeInterventional
Ages4 Years to 12 Years
SexAll
Enrollment135 (estimated)
SponsorDiskapi Yildirim Beyazit Education and Research Hospital
Government
Locations1 site (Ankara)
StatusRecruiting
StartedJuly 26, 2026
Main results expectedAugust 19, 2026
Study endsSeptember 1, 2026
Registry record updatedJuly 28, 2026
Trial IDNCT07410078 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Pediatric patients aged 4–12 years with ASA I–II undergoing elective ambulatory surgery who can receive oral premedication and complete behavioral and pain assessments.

Probably not a fit

Results may not apply to children with higher ASA status, certain neurodevelopmental conditions, or allergies to the study drugs.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This prospective, three-arm interventional study compares oral midazolam alone, midazolam with ibuprofen, and midazolam with ketamine in children undergoing elective day-case surgery. The primary outcome is the rate of well-tolerated venipuncture using behavioral and pain scales. Secondary outcomes include anxiety levels, venipuncture success metrics, time to IV access, and satisfaction from parents and anesthesiologists. A predefined rescue inhalational induction protocol is available if premedication is inadequate or venous access fails. The aim is to identify premedication regimens that improve cooperation and reduce distress during venous cannulation in pediatric anesthesia.

Why it matters

Potential benefit: If successful, the results could guide safer, more tolerable premedication strategies for pediatric venipuncture in ambulatory settings.

How similar studies have gone: Previous research supports using midazolam for pediatric premedication; combining it with other agents is an area of ongoing study with variable outcomes.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Pediatric patients aged 4-12 years
* American Society of Anesthesiologists (ASA) physical status I-II
* Scheduled for elective ambulatory (day-case) surgery
* Eligible to receive oral premedication
* Cognitive ability sufficient to complete behavioral and pain scale assessments
* Written informed consent obtained from a parent or legal guardian

Exclusion Criteria:

* ASA physical status III or higher
* Moderate to severe intellectual disability
* Moderate to severe autism spectrum disorder
* Known allergy or contraindication to midazolam, ketamine, or ibuprofen
* History of sedative or opioid use within the previous 24 hours
* Complete loss of premedication due to vomiting

Where it's running

  • Ankara Etlik City Hospital
    Ankara, Turkey (Türkiye)
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.